Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546865 | 0.98 | MEN1 (0.51) | MEN1KMT2ACYP19A1RAB9AMAPT | |
| SCHEMBL4546883 | 0.96 | MEN1 (0.50) | MEN1KMT2ACYP19A1RAB9AKDM4E | |
| SCHEMBL4546989 | 0.95 | MEN1 (0.57) | MEN1KMT2ACYP19A1RAB9AMAPT | |
| SCHEMBL4546870 | 0.94 | MEN1 (0.51) | MEN1KMT2ACYP19A1RAB9AKDM4E | |
| SCHEMBL4546984 | 0.94 | MEN1 (0.51) | MEN1KMT2ACYP19A1RAB9AKDM4E | |
| SCHEMBL4546993 | 0.94 | MEN1 (0.51) | MEN1KMT2ACYP19A1RAB9AKDM4E | |
| SCHEMBL4546881 | 0.94 | MEN1 (0.51) | MEN1KMT2ACYP19A1RAB9AKDM4E | |
| SCHEMBL4546952 | 0.94 | MEN1 (0.51) | MEN1KMT2ACYP19A1RAB9AKDM4E | |
| SCHEMBL4546885 | 0.93 | MEN1 (0.50) | MEN1KMT2ACYP19A1RAB9AMAPT | |
| SCHEMBL4546887 | 0.93 | MEN1 (0.50) | MEN1KMT2ACYP19A1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLCO4C1, SLCO2A1, SLCO2B1 | MEN1 1984/4885KMT2A 1753/4885CYP19A1 1485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.